Dr. Gandhi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
150 Parkway Office Ct
Suite 200
Cary, NC 27518Phone+1 984-974-2150Fax+1 984-974-2151- Is this information wrong?
Summary
- I am board certified in Medical Oncology, Hematology, and Internal Medicine.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Icahn School of Medicine at Mount Sinai/Morningside/WestChief Residency, Internal Medicine, 2015 - 2016- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2012 - 2015
The Pennsylvania State UniversityPhD, Molecular Toxicology, 2007 - 2012
N.H.L Municipal Medical CollegeClass of 2007, MBBS
Certifications & Licensure
NC State Medical License 2019 - 2025
TN State Medical License 2017 - 2020
NY State Medical License 2016 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected as Chief Resident Mount Sinai St. Luke's Roosevelt Hospital, 2015-2016
- US Patent # 8,802,680 2014
- Honors in Anatomy Smt. NHL Municipal Medical College, Ahmedabad, India, 2002
Publications & Presentations
PubMed
- Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells.Gandhi, U. H., Qian, F., Nettleford, S., Zhou, J., Arner, B., Hall, M., Sharma, A., Annageldiyev, C., Rossi, R., Tukaramrao, D., Sarkar, D., Hegde, S., Gandhi, U., Fin...> ;Cell Reports. 2023 Jul 25
- 20 citationsOverall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH., , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;American Journal of Hematology. 2021 Jan 1
- 357 citationsOutcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy., , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Leukemia. 2019 Sep 1
- Join now to see all
Research History
- Graduate Research AssistantPenn State University, PhD - Molecular Toxicology2008 - 2012
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Hindi, Gujarati
Hospital Affiliations
UNC REX Health CareRaleigh, North Carolina
External Links
- Practice profilehttps://findadoc.unchealthcare.org/details/47230/ujjawal-gandhi-cancer-hematology-cary
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
